Kalehua Capital Management LLC

Kalehua Capital Management LLC is a healthcare-focused investment firm specializing in biopharmaceutical investments. The firm employs a science-driven approach to invest in small-cap public and late-stage private biopharmaceutical companies developing transformative therapies to improve patients' lives. Their long-term investment strategy is built on deep industry expertise and a commitment to driving meaningful impact in healthcare.

The firm's investment focus includes private equity and venture capital, targeting early-stage, growth, and late-stage companies within the biopharmaceutical sector. Geographically, Kalehua Capital concentrates its investments within the United States, emphasizing the healthcare industry.

Kalehua Capital's portfolio includes investments in companies such as Aadi Bioscience, Surrozen, and Oruka Therapeutics. The firm typically invests between $5 million and $50 million per company, reflecting its commitment to supporting innovative biopharmaceutical companies at various stages of development.